Could diabetes medications have an influence beyond simply regulating blood sugar? This question is gaining ground in ...

Diabetes drugs may be doing more than managing blood sugar, they could also shape cancer biology in unexpected ways.

Groundbreaking research reveals that common blood sugar medications do more than manage glucose—they are actively reshaping ...

Among diabetes drugs, GLP-1 receptor agonists and SGLT2 inhibitors were associated with greater reduction in the risk for Alzheimer’s disease (AD) than DPP-4 inhibitors, new research showed. “GLP-1 ...

The landscape of diabetes management is undergoing a remarkable transformation. Groundbreaking research has uncovered surprising cardiovascular benefits tied to modern medications, offering new hope ...

A groundbreaking development in diabetes treatment reveals that SGLT-2 inhibitors significantly reduce dementia risk among type 2 diabetes patients. Recent research demonstrates these medications ...

People lost substantially more weight when they took Eli Lilly's diabetes drug Mounjaro than Novo Nordisk's Ozempic, with roughly the same side effects, drop-out rate and benefit for diabetes, ...

Ozempic, Wegovy and other GLP-1 medications have gained widespread popularity for weight loss and diabetes control in recent years — but the spike in demand has made it difficult for some people to ...